BULLOUS PEMPHIGOID (BP)

Clinical trials for BULLOUS PEMPHIGOID (BP) explained in plain language.

Never miss a new study

Get alerted when new BULLOUS PEMPHIGOID (BP) trials appear

Sign up with your email to follow new studies for BULLOUS PEMPHIGOID (BP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New shot could help blistering skin disease patients stop steroids

Disease control Not yet recruiting

This study tests a new drug called stapokibart for people with moderate to severe bullous pemphigoid, a painful blistering skin condition. About 200 adults will receive either the drug or a placebo to see if it helps them stop taking steroids and stay blister-free for 36 weeks. T…

Matched conditions: BULLOUS PEMPHIGOID (BP)

Phase: PHASE3 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Disease control

Last updated May 07, 2026 18:40 UTC

BULLOUS PEMPHIGOID (BP)

Get alerted when new BULLOUS PEMPHIGOID (BP) trials appear

New shot could help blistering skin disease patients stop steroids